Litcius/Paper detail

Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial

Staffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, Marie Fredslund Breinholt, Lone Schejbel, Mette Klarskov Andersen, Mohammad Kadivar, Inge Marie Svane, Kirsten Grønbæk, Sine Reker Hadrup, Daniel El Fassi

2021Cancer Immunology Immunotherapy15 citationsDOIOpen Access PDF

Topics & Concepts

AzacitidineMedicineMyelodysplastic syndromesAntigenHypomethylating agentELISPOTImmunotherapyEpigenetic therapyImmunologyClinical trialDecitabineOncologyInternal medicineImmune systemBone marrowBiologyDNA methylationCD8Gene expressionBiochemistryGeneAcute Myeloid Leukemia ResearchImmune cells in cancerImmunotherapy and Immune Responses
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial | Litcius